S&P 500 Earnings: Forward S&P 500 Estimates Still Rising; Oracle Reports This Week

Forward S&P 500 earnings estimates remain elevated, with aggregate S&P 500 earnings expected to grow 14% in 2026 and Q4 ’25 results scheduled to begin on Jan. 10, 2026, which should sharpen 2026 guidance. Major corporate prints on Dec. 11 include Oracle’s fiscal Q2 ’26 report — notable because Oracle’s CDS spreads have widened, implying higher perceived default risk — and Costco’s quarterly results, with the stock roughly $175 below its Feb. ’25 high of $1,078 and trading beneath both its 50- and 200-day moving averages.

Analysis

Market structure: Oracle's CDS widening and Costco's slide signal idiosyncratic stress rather than sector breakdown; software vendors with large legacy on-prem footprints (ORCL) and capital-heavy retail (COST) are direct losers while cloud-native peers and broadline discounters can benefit via share shift and less pricing pressure. Credit-market moves suggest lenders demand higher risk premia (HY spreads and bank loan pricing), raising corporate funding costs that can compress buybacks and M&A in H1 2026. Options IV will rise into Oracle's Dec 11 print and S&P guidance window, creating asymmetric trade opportunities.

Risk assessment: Immediate (days) risk = earnings/guide shocks on Dec 11 and corresponding CDS repricing; short-term (weeks/months) risk = 2026 earnings-guide downgrades vs the current 14% S&P consensus; long-term (quarters) risk = sustained credit spread widening feeding into lower equity multiples. Tail scenarios: ORCL rating action or a >200–300bp persistent CDS move could force covenant/financing stress; for COST, a comp miss >2–3% could trigger multiple contraction. Hidden dependency: corporate buyback cadence and tech capex cycles amplify equity sensitivity.

Trade implications: Tactical: play ORCL skew — prefer defined-risk bearish exposure into earnings (3-month 10–15% OTM put spreads, sold calls to fund) sized 0.5–1.5% of portfolio; avoid expensive straddles. For COST, trim concentrated long exposure (reduce position by 25–40% if >2% weight) and implement a relative-value pair (long WMT, short COST, size 1–1.5% net) to capture share shifts. Macro hedge: buy 3-month SPX 5% OTM puts sized to cover 2% portfolio downside risk into the Q4 guide window.

Contrarian angles: The market may be conflating technical CDS flows with fundamental default risk — if ORCL equity reaction exceeds 15% on Dec 11 without credit events, opportunistic buys are warranted (accumulate up to 1% position). Conversely, consensus may underprice a guidance-driven S&P earnings reset; set alarms: add protection if S&P forward EPS revision turns negative for two consecutive weeks or if aggregate buyback guidance falls >20% YoY.

Key Decisions for Investors

• Establish a hedged bearish ORCL position before Dec 11: buy 3-month ORCL put spreads 10–15% OTM and sell 5–10% OTM calls to fund, sizing at 0.5–1.5% of portfolio; close or re-assess within 2 weeks after print or if ORCL CDS falls below 150 bps.
• Reduce concentrated COST exposure: trim 25–40% of any position that exceeds 2% portfolio weight; if COST reports same-store sales decline >2% or trades under $850 (≈>6% further downside from $903), increase reduction to 50% and rotate into WMT (initiate 1% long) while shorting 1–1.5% COST for pair trade.
• Implement macro hedge: purchase 3-month SPX 5% OTM puts sized to cover a 2% portfolio drawdown ahead of Q4 earnings/guidance season; review after January 10, 2026 earnings flow and unwind if S&P forward EPS revisions remain + or buyback guidance intact.
• Set objective credit/entry triggers for contrarian ORCL accumulation: if ORCL equity gaps down >15% on Dec 11 without a rating action or if 5-yr CDS >300 bps persist for 5 trading days, initiate staged accumulation up to 1% portfolio; if CDS >400 bps or rating downgrade occurs, avoid equity and prefer credit protection exits.